Product Details:
| Strength | 4 mg |
| Brand | Pomide |
| Salt | Pomalidomide |
| Pack Size | 21 Capsules |
| Pack Type | Box |
| Drug Form | Capsule |
| Medicine Brand | HETERO Pomide |
| Medicine Form | Capsules |
| Medicine Name | Pomalidomide Capsules |
| Medicine Strength | 4 mg |
| Packaging Size | 21 capsules |
| Salt Composition | Pomalidomide |
| Uses of Medicine | ONCOLOGY |
Product Details:
| Minimum Order Quantity | 3 Bottle |
| Packaging Size | 30 caps |
| Prescription/Non prescription | Prescription |
| Composition | Ibrutinib |
| Brand | Hetro |
| Treatment | Nitib is indicated for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia / Small Lymphocytic Lympho |
| Manufacturer | hetro |
Nitib 140 is indicated for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma, Waldenstrom's Macroglobulinemia, Marginal zone Lymphoma, Chronic Graft Versus Host Disease. Ibrutinib is a first line treatment in those with CLL who require treatment and are newly diagnosed.